Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInvestment IncomeNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Tax ProvisionsTax Rate
Others
Ratios

Fresenius Medical Care AG (FMS) Operating Income: 2009-2024

Historic Operating Income for Fresenius Medical Care AG (FMS) over the last 16 years, with Dec 2024 value amounting to $1.5 billion.

  • Fresenius Medical Care AG's Operating Income rose 9.63% to $557.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 billion, marking a year-over-year decrease of 1.80%. This contributed to the annual value of $1.5 billion for FY2024, which is 0.44% up from last year.
  • As of FY2024, Fresenius Medical Care AG's Operating Income stood at $1.5 billion, which was up 0.44% from $1.5 billion recorded in FY2023.
  • Over the past 5 years, Fresenius Medical Care AG's Operating Income peaked at $2.6 billion during FY2020, and registered a low of $1.5 billion during FY2023.
  • Over the past 3 years, Fresenius Medical Care AG's median Operating Income value was $1.5 billion (recorded in 2024), while the average stood at $1.5 billion.
  • In the last 5 years, Fresenius Medical Care AG's Operating Income increased by 3.52% in 2020 and then decreased by 27.31% in 2022.
  • Over the past 5 years, Fresenius Medical Care AG's Operating Income (MRY) stood at $2.6 billion in 2020, then decreased by 16.69% to $2.2 billion in 2021, then decreased by 27.31% to $1.6 billion in 2022, then dropped by 7.03% to $1.5 billion in 2023, then rose by 0.44% to $1.5 billion in 2024.
  • Its Operating Income stands at $1.5 billion for FY2024, versus $1.5 billion for FY2023 and $1.6 billion for FY2022.